GE Medical Systems has signed an agreement to supply its PET scanners to Mobile P.E.T. Systems. The deal gives GE access to Mobile P.E.T.’s network of clients, while Mobile P.E.T. can employ GE’s service program and clinical and technical
GE Medical Systems has signed an agreement to supply its PET scanners to Mobile P.E.T. Systems. The deal gives GE access to Mobile P.E.T.s network of clients, while Mobile P.E.T. can employ GEs service program and clinical and technical training for physicians.
San Diego-based Mobile P.E.T. plans to install its first GE unit in the fourth quarter of 1999 at its new PET center in London, while the first mobile units will be installed in early 2000. The company has placed an initial order for seven mobile PET units from Milwaukee-based GE for the coming year, according to Paul Crowe, Mobile P.E.T. CEO.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.